Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Centre for Statistics in Medicine


Statistics expertise for medical and healthcare research

We collaborate with researchers across the UK and the globe to conduct world-class medical and healthcare research, aiming to advance healthcare practice and policy. We are committed to improving the standard of medical research methodology through research on research and methods development. We champion transparent and complete reporting of health research through reporting guidelines and training provision.

20 years experience in medical statistics

80+ current trials

Team of medical statisticians, epidemiologists, methodologists and systematic review specialists

Home of the Oxford Clinical Trials Research Unit (OCTRU) and the UK EQUATOR Centre

Latest CSM news

3,400 different medicines used globally to treat COVID-19

Insufficient data, and misleading recommendations led to significant early heterogeneity in global COVID-19 patient management, according to recent BMJ study

Understanding the first wave of COVID-19 and implications for tackling the ongoing pandemic: evidence from 5.5 million people from Catalonia, Spain

Health outcomes during the first wave of COVID-19 in Catalonia, Spain, have been described in detail in a study published by Nature Communications.

Patients set to benefit from new guidelines on Artificial Intelligence health solutions

Patients could benefit from a faster and more effective introduction of artificial intelligence (AI) innovations to diagnose and treat disease – thanks to the first international standards for reporting of clinical trials for AI.

Grant towards OHDSI Global Research on COVID-19 treatments

An international cohort of OHDSI collaborators obtain a grant from the COVID-19 Therapeutics Accelerator to lead an effort to compare the effectiveness of treatments, including corticosteroids such as dexamethasone, under current evaluation for COVID-19 across an international observational data network.